[Changes of thymocyte differentiation, proliferation and apoptosis induced by syntetic peptides].
Iarilin. A A AA; Khavinson. V Kh VKh; Poliakova. V O VO; Lin'kova. N S NS; Kvetnoĭ. I M IM
Key Findings
- T-32 and T-38 increased the conversion of immature cortical thymocytes (CD4+CD8+) into regulatory T‑cells (CD4+CD25+).
- Both peptides raised the proliferation rate of these cells and lowered their apoptosis (programmed cell death).
- Mature regulatory T‑cells also showed higher growth and survival when exposed to the peptides.
Practical Outcomes
- The results suggest these peptides might support immune regulation, which could be interesting for longevity or health‑optimization goals. However, the work was done only in cell cultures, so there is no dosage guidance or safety data for humans. More animal and clinical studies are needed before anyone can responsibly use these peptides in a real‑world protocol.
Summary
A lab study showed that two synthetic peptides, called T-32 and T-38, can help immature immune cells (thymocytes) turn into regulatory T‑cells, which are important for keeping the immune system balanced. The peptides also made these cells grow more and die less, and they boosted the same effects in already‑mature regulatory T‑cells.
Abstract
The changes in the processes of differentiation, proliferation and apoptosis were studied in the culture of human cortical thymocytes after cell exposure to T-32 and T-38 bioregulator peptides. T-32 and T-38 peptides were shown to enhance the differentiation of immature cortical thymocytes (CD4+CD8+) into T-regulatory cells by increasing their proliferate activity and decreasing the level of apoptosis. Moreover, these peptides were found to stimulate the proliferative and antiapoptotic activity of mature T-regulatory (CD4+CD25+) cells.
Study Information
pubmed
2011